Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,760 | -20,557 | -3,256 | -73,790 | -58,193 |
| Depreciation Amortization | -2,144 | -1,223 | -172 | -2,861 | -2,110 |
| Accounts receivable | N/A | N/A | -8,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,210 | 1,812 | -1,365 | -3,507 | -3,857 |
| Other Working Capital | -5,164 | -9,463 | -21,766 | -11,664 | -9,356 |
| Other Operating Activity | 9,476 | 5,714 | 13,849 | 21,113 | 18,061 |
| Operating Cash Flow | $-38,382 | $-23,717 | $-20,710 | $-70,709 | $-55,455 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,265 | -18,257 | -18,261 | -104,783 | -115,010 |
| PPE Investments | -237 | -237 | -237 | -6,726 | -6,726 |
| Net Acquisitions | N/A | N/A | N/A | 6,660 | 6,659 |
| Investing Cash Flow | $-18,502 | $-18,494 | $-18,498 | $-104,849 | $-115,077 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 59,516 | 57,860 | 57,707 | 6,374 | 6,347 |
| Other Financing Activity | -240 | -239 | -196 | -445 | -393 |
| Financing Cash Flow | $59,276 | $57,621 | $57,511 | $5,929 | $5,954 |
| Beginning Cash Position | 11,136 | 11,136 | 11,136 | 180,765 | 180,765 |
| End Cash Position | 13,528 | 26,546 | 29,439 | 11,136 | 16,187 |
| Net Cash Flow | $2,392 | $15,410 | $18,303 | $-169,629 | $-164,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,382 | -23,717 | -20,710 | -70,709 | -55,455 |
| Capital Expenditure | -237 | -237 | -237 | -6,726 | -6,726 |
| Free Cash Flow | -38,619 | -23,954 | -20,947 | -77,435 | -62,181 |